Access to diabetes drugs in New Zealand is inadequate

Show simple item record Krebs, J en Coppell, KJ en Cresswell, P en Downie, M en Drury, P en Gregory, A en Kenealy, Timothy en McNamara, C en Miller, SC en Smallman, K en 2017-11-26T21:02:55Z en 2016-06-10 en
dc.identifier.citation New Zealand Medical Journal 129(1436):6-9 10 Jun 2016 en
dc.identifier.issn 0028-8446 en
dc.identifier.uri en
dc.description.abstract New Zealand is well behind the rest of the developed world in access to funded drugs for managing type 2 diabetes. Over the last 12 years three new classes of glucose-lowering drugs have come through clinical trials to market. The principal strengths of all three novel classes of medicine are their lack of hypoglycaemia (low blood sugar), their frequent acceptability in patients intolerant of or contraindicated for existing funded drugs, and avoidance of weight gain. International guidelines focus on individualization of treatment and avoidance of hypoglycaemia. This is extremely difficult for New Zealanders with type 2 diabetes when we do not have access to modern drug treatments. en
dc.format.medium Electronic en
dc.language eng en
dc.publisher New Zealand Medical Association en
dc.relation.ispartofseries New Zealand Medical Journal en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri en
dc.subject Humans en
dc.subject Diabetes Mellitus, Type 2 en
dc.subject Hypoglycemia en
dc.subject Hemoglobin A, Glycosylated en
dc.subject Hypoglycemic Agents en
dc.subject Drug Costs en
dc.subject Financing, Government en
dc.subject Health Services Accessibility en
dc.subject New Zealand en
dc.subject Sodium-Glucose Transporter 2 en
dc.subject Glucagon-Like Peptide 1 en
dc.subject Practice Guidelines as Topic en
dc.subject Dipeptidyl-Peptidase IV Inhibitors en
dc.subject Healthcare Financing en
dc.title Access to diabetes drugs in New Zealand is inadequate en
dc.type Journal Article en
pubs.issue 1436 en
pubs.begin-page 6 en
pubs.volume 129 en
dc.description.version VoR - Version of Record en
dc.rights.holder Copyright: New Zealand Medical Association en
dc.identifier.pmid 27355224 en
pubs.end-page 9 en
pubs.publication-status Published en
dc.rights.accessrights en
pubs.subtype Editorial Comment en
pubs.elements-id 603766 en Medical and Health Sciences en School of Medicine en Medicine Department en
dc.identifier.eissn 1175-8716 en
pubs.record-created-at-source-date 2017-11-27 en
pubs.dimensions-id 27355224 en

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace